Lopicast - A Drug to Fight Coronavirus

▴ Lopicast - A Drug to Fight Coronavirus
Aprazer Healthcare (p) Ltd.is providng Lopicast - a lifesaving drug for coronavirus at affordable prices. Lopicast is having composition of Ritonavir 50 mg & Lopinavir 200 mg which are recommended to use in coronavirus cases

The endemic of coronavirus started from Wuhan city of China and is knocking the doors of different countries of the world. The deadly symptoms of Coronavirus have put many lives at risk in various regions of the world with maximum effect in Asia especially in China. Continuous attempts are been made to find cure for this virus however considering the growing number of cases doctors have decided to look for some unconventional remedies.

Lopinavir Ritonavir A drug developed to cure HIV infections is used in the treatment of Coronavirus cases. Two antiretroviral components lopinavir and ritonavir are protease inhibitors designed to block HIV viral replication. One hypothesis holds that the drugs could do the same with 2019-nCoV (Coronavirus) which is believed to have originated from the Chinese city of Wuhan.

LOPIKASTis a Generic version of Kaletra now recommended as a treatment for pneumonia caused by the new coronavirus known as 2019-nCoV China National Health Commission says in its updated clinical guidance. Wang Guangfa the leader of Peking University First Hospital pulmonary and critical care medicine department contracted the virus as a member of a national expert team dispatched to Wuhan. Lopinavir Ritonavir tabletskilled his disease Wang told state-run China News Service in areport(Chinese) recently.

In India Aprazer Healthcare Private Limited is a pharmaceutical company based at Delhi which is continuously evolving by providing lifesaving drugs at affordable prices. Aprazer Healthcare Private Limited markets LOPIKAST having composition of Ritonavir 50 mg and Lopinavir 200 mg. As this drug is recommended to use in Coronavirus cases the company has started exporting the product to China and other flu-prone regions at economical prices. The company offers reduced prices of this life-saving drug so that it is easily accessible. Announcing the measures taken by Aprazer Healthcare Pvt. Ltd. CEO of the Company Aprazer said At Aprazer our endeavour is to contribute by supplying the LOPIKAST tablets at the all-time low prices.

He further added that This drug at cost-effective prices will prove to be a stronger response to the prevailing crisis. As it a global emergency we have to face it together.Further he states that If a person is suffering from the expected symptoms of Coronavirus must visit doctor immediately. Lopikast shouldn;t be taken without recommendation and prescription of Physician. According to the doctors treating infected patients of Coronavirus the medicine is not a complete cure for the ailment. However after taking the medicine in combination with flu drug and HIV drug to an infected person the symptoms are expected to improve considerably.

Aprazer Healthcare Pvt. Ltd. has already begun to supply LOPIKAST tablets in the hospitals and cure centres across China. Coronavirus outbreak in China is screaming for assistance from all over the world. The sensitive approach of Aprazers is what other companies should replicate as rightly quoted by Mr. Gandhi. Sometimes profit is not a consideration.

Tags : #Coronavirus #Aprazerhealthcare #Lopicast #Healthcare

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024
IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024